Skip to main content
Equibles

CAPITAL ADVISORS INC/OK

Position in CRSP — CRISPR Therapeutics AG

CIK 860828 TULSA, OK
Back to CRSP Full portfolio

Position in CRSP

as of Jun 30, 2026 · filed Jul 23, 2026
Position Value
$272,154
+$34,780 QoQ
Shares Held
4,990
0.0% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#284
of 522 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in CRSP Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

CAPITAL ADVISORS INC/OK holds $361,254 across 2 Biotechnology names. CRSP ranks #1 (75.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 CRSP
CRISPR Therapeutics AG
This page 		4,990 $272,154
2 KYTX
Kyverna Therapeutics, Inc.
 10,000 $89,100

All Filings in CRSP

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $272,154 4,990
2026-03-31 $237,374 4,990
2025-12-31 $263,982 5,034
2025-09-30 $333,058 5,139
2025-06-30 $340,090 6,992
2025-03-31 $10,464,156 307,498
2024-12-31 $12,212,227 310,270
2024-09-30 $14,121,671 300,589
2024-06-30 $15,015,104 278,006
2024-03-31 $17,993,285 263,986
2023-12-31 $15,979,589 255,265
2023-09-30 $10,527,075 231,925
2023-06-30 $12,124,780 215,974
2023-03-31 $7,498,274 165,781
2022-12-31 $5,281,004 129,914
2022-09-30 $8,388,456 128,362
2022-06-30 $7,650,031 125,885
2022-03-31 $6,589,720 104,982
2021-12-31 $7,765,328 102,472
2021-09-30 $7,910,316 70,672
2021-06-30 $11,248,279 69,481
2021-03-31 $8,256,190 67,757
2020-12-31 $13,422,847 87,668
2020-09-30 $11,450,316 136,900
2020-06-30 $10,031,164 136,497
2020-03-31 $5,665,085 133,579